Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Eliezer

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Investigation of All Disease-Relevant Lysine Acetylation Sites in α-Synuclein Enabled by Non-canonical Amino Acid MutagenesisMarie Shimogawa, Ming-Hao Li, Grace Shin Hye Park, et al.
Frontiers in Aging Neuroscience|August 21, 2014
Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicityMustafa T Ardah, Katerina E Paleologou, Guohua Lv, et al.
Angewandte Chemie (International Ed. in English)|November 7, 2019
3-O-Sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular UptakeJing Zhao, Yanan Zhu, Xuehong Song, et al.
The Journal of Biological Chemistry|February 9, 2012
α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomerBruno Fauvet, Martial K Mbefo, Mohamed-Bilal Fares, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 6, 2010
Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactionsKaterina E Paleologou, Abid Oueslati, Gideon Shakked, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Genetic Code Expansion and Enzymatic Modifications as Accessible Methods for Studying Site-Specific Post-Translational Modifications of Alpha-Synuclein and TauIbrahim G Saleh, Marie Shimogawa, Jennifer Ramirez, et al.
Nature Communications|January 11, 2022
Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's diseaseYun Yang, Victor Tapias, Diana Acosta, et al.
Protein Science : a Publication of the Protein Society|September 13, 2025
Genetic code expansion and enzymatic modifications as accessible methods for studying site-specific post-translational modifications of alpha-synuclein and tauIbrahim G Saleh, Marie Shimogawa, Jennifer Ramirez, et al.
Acta Biomaterialia|June 7, 2024
Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's diseaseWei Zhang, Nathan Smith, Yiqun Zhou, et al.
Nature Structural & Molecular Biology|September 8, 2012
In support of the BMRBJohn L Markley, Hideo Akutsu, Tetsuo Asakura, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Investigation of All Disease-Relevant Lysine Acetylation Sites in α-Synuclein Enabled by Non-canonical Amino Acid MutagenesisMarie Shimogawa, Ming-Hao Li, Grace Shin Hye Park, et al.
Frontiers in Aging Neuroscience|August 21, 2014
Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicityMustafa T Ardah, Katerina E Paleologou, Guohua Lv, et al.
Angewandte Chemie (International Ed. in English)|November 7, 2019
3-O-Sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular UptakeJing Zhao, Yanan Zhu, Xuehong Song, et al.
The Journal of Biological Chemistry|February 9, 2012
α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomerBruno Fauvet, Martial K Mbefo, Mohamed-Bilal Fares, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 6, 2010
Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactionsKaterina E Paleologou, Abid Oueslati, Gideon Shakked, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Genetic Code Expansion and Enzymatic Modifications as Accessible Methods for Studying Site-Specific Post-Translational Modifications of Alpha-Synuclein and TauIbrahim G Saleh, Marie Shimogawa, Jennifer Ramirez, et al.
Nature Communications|January 11, 2022
Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's diseaseYun Yang, Victor Tapias, Diana Acosta, et al.
Protein Science : a Publication of the Protein Society|September 13, 2025
Genetic code expansion and enzymatic modifications as accessible methods for studying site-specific post-translational modifications of alpha-synuclein and tauIbrahim G Saleh, Marie Shimogawa, Jennifer Ramirez, et al.
Acta Biomaterialia|June 7, 2024
Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's diseaseWei Zhang, Nathan Smith, Yiqun Zhou, et al.
Nature Structural & Molecular Biology|September 8, 2012
In support of the BMRBJohn L Markley, Hideo Akutsu, Tetsuo Asakura, et al.
Pageof 12